172 related articles for article (PubMed ID: 18294981)
21. Novel oral anticoagulants for the prevention of thromboembolism in patients with atrial fibrillation.
Lang NN; Connelly DT
J R Coll Physicians Edinb; 2013; 43(2):151-8. PubMed ID: 23734359
[TBL] [Abstract][Full Text] [Related]
22. [Stroke prevention in atrial fibrillation. Marcumar alternative in sight].
Einecke D
MMW Fortschr Med; 2009 Sep; 151(38):12-4. PubMed ID: 19831172
[No Abstract] [Full Text] [Related]
23. Clopidogrel plus aspirin in atrial fibrillation.
Richard T; Butaffuoco F; Vanhaeverbeek M
N Engl J Med; 2009 Sep; 361(13):1313; author reply 1314-5. PubMed ID: 19780216
[No Abstract] [Full Text] [Related]
24. Prevention of stroke in patients with atrial fibrillation.
Med Lett Drugs Ther; 2009 Jun; 51(1313):41. PubMed ID: 19478692
[No Abstract] [Full Text] [Related]
25. Comparative efficacy and safety of the non-vitamin K antagonist oral anticoagulants for patients with nonvalvular atrial fibrillation.
Senoo K; Lip GY
Semin Thromb Hemost; 2015 Mar; 41(2):146-53. PubMed ID: 25682085
[TBL] [Abstract][Full Text] [Related]
26. Comparison of the short-term risk of bleeding and arterial thromboembolic events in nonvalvular atrial fibrillation patients newly treated with dabigatran or rivaroxaban versus vitamin K antagonists: a French nationwide propensity-matched cohort study.
Maura G; Blotière PO; Bouillon K; Billionnet C; Ricordeau P; Alla F; Zureik M
Circulation; 2015 Sep; 132(13):1252-60. PubMed ID: 26199338
[TBL] [Abstract][Full Text] [Related]
27. Prevention of stroke in patients with atrial fibrillation.
Olsson SB; Halperin JL
Semin Vasc Med; 2005 Aug; 5(3):285-92. PubMed ID: 16123916
[TBL] [Abstract][Full Text] [Related]
28. Elevated international normalized ratio from vitamin K supplement discontinuation.
Miesner AR; Sullivan TS
Ann Pharmacother; 2011 Jan; 45(1):e2. PubMed ID: 21205949
[TBL] [Abstract][Full Text] [Related]
29. A new era for anticoagulation in atrial fibrillation. Which anticoagulant should we choose for long‑term prevention of thromboembolic complications in patients with atrial fibrillation?
Riva N; Lip GY
Pol Arch Med Wewn; 2012; 122(1-2):45-53. PubMed ID: 22353706
[TBL] [Abstract][Full Text] [Related]
30. Development of a novel composite stroke and bleeding risk score in patients with atrial fibrillation: the AMADEUS Study.
Lip GYH; Lane DA; Buller H; Apostolakis S
Chest; 2013 Dec; 144(6):1839-1847. PubMed ID: 24009027
[TBL] [Abstract][Full Text] [Related]
31. Bleeding risk on warfarin among elderly patients with atrial fibrillation.
Cowan A; Hylek EM
J Am Coll Cardiol; 2010 Mar; 55(9):932; author reply 932-3. PubMed ID: 20185052
[No Abstract] [Full Text] [Related]
32. Use of Vitamins K antagonists in non-valvular atrial fibrillation thromboembolic risk prevention in Burkina Faso.
Yameogo AR; Kologo JK; Mandi G; Kabore HP; Millogo GR; Seghda AA; Samadoulougou AK; Zabsonre P
Pan Afr Med J; 2016; 24():108. PubMed ID: 27642447
[TBL] [Abstract][Full Text] [Related]
33. Warfarin for stroke prevention in atrial fibrillation: time to switch?
Ahmad Y; Lip GY
Int J Clin Pract; 2013 Jul; 67(7):603-5. PubMed ID: 23758442
[No Abstract] [Full Text] [Related]
34. Balancing bleeding and thrombotic risk with new oral anticoagulants in patients with atrial fibrillation.
Overvad TF; Larsen TB; Albertsen IE; Rasmussen LH; Lip GY
Expert Rev Cardiovasc Ther; 2013 Dec; 11(12):1619-29. PubMed ID: 24215192
[TBL] [Abstract][Full Text] [Related]
35. [Bleeding during anti-vitamin K treatment. Incidence, risk factors and comparison with the new oral anticoagulants].
Korin J
Medicina (B Aires); 2012; 72(5):419-24. PubMed ID: 23089119
[TBL] [Abstract][Full Text] [Related]
36. [Antithrombotic treatment in atrial fibrillation. Background to new recommendations and therapeutic alternative].
Själander A; Wallentin L; Rosenqvist M; Svensson P
Lakartidningen; 2008 Sep 10-16; 105(37):2478-80. PubMed ID: 19006862
[No Abstract] [Full Text] [Related]
37. Anticoagulation and Renal Insufficiency.
Koulouri A; Calanca L; Mazzolai L
Ther Umsch; 2016; 73(10):567-572. PubMed ID: 28045357
[No Abstract] [Full Text] [Related]
38. Apixaban versus warfarin in patients with atrial fibrillation according to prior warfarin use: results from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation trial.
Garcia DA; Wallentin L; Lopes RD; Thomas L; Alexander JH; Hylek EM; Ansell J; Hanna M; Lanas F; Flaker G; Commerford P; Xavier D; Vinereanu D; Yang H; Granger CB
Am Heart J; 2013 Sep; 166(3):549-58. PubMed ID: 24016506
[TBL] [Abstract][Full Text] [Related]
39. Rivaroxaban and stroke prevention in patients with atrial fibrillation: new evidence.
Martínez-Rubio A; Dan GA; Kaski JC
Expert Rev Cardiovasc Ther; 2014 Aug; 12(8):933-47. PubMed ID: 24948333
[TBL] [Abstract][Full Text] [Related]
40. Stroke prevention in atrial fibrillation.
Freedman B; Potpara TS; Lip GY
Lancet; 2016 Aug; 388(10046):806-17. PubMed ID: 27560276
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
